GNC Hits Revenue Wrinkles As It Irons Out Marketing, Franchise Shifts
This article was originally published in The Tan Sheet
Executive Summary
Based on first-quarter revenues, GNC lowers its full-year EPS guidance to $2.80-$2.90. CEO Mike Archbold says significant price markdowns, overall under-performance in vitamin sales, disappointing marketing results and weakness in franchisees adopting corporate initiatives contributed to a 1.8% drop in revenues.
You may also be interested in...
GNC Makes Change At Helm As Revenue Decline Continues
The firm reports lower second-quarter revenues across its retail operations, domestically and internationally, and for company and franchise stores, and a 2.4% drop in consolidated revenues to $673.2m. Same-store sales, including its website, were off 3.7% and net income slipped 5% to $64m.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.